Sharon Flank, CEO of InfraTrac, provides anti-counterfeiting solutions to the pharmaceutical industry as well as electronic parts, and has recently created solutions for protecting 3D printing. An entrepreneur with a background in software, she founded InfraTrac in 2006, expanding on technology originally developed at the University of Maryland. InfraTrac develops product protection solutions that rely on spectroscopy. At eMotion and SRA International, Dr. Flank led technical efforts for successful commercial products, and helped create companies later sold to AOL and Kodak.

She is the author of numerous journal articles, on anti-counterfeiting, medication errors, search engines, and natural language processing. Dr. Flank holds ten patents. She received her A.B. from Cornell and her Ph.D. from Harvard.